- Home
- JANX vs EXPI Comparison
JANX vs EXPI Comparison
Compare JANX & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JANX | EXPI |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | JANX | EXPI |
|---|---|---|
| Price | $14.16 | $9.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $60.27 | $12.00 |
| AVG Volume (30 Days) | ★ 3.3M | 951.1K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,000,000.00 | ★ $4,678,653,000.00 |
| Revenue This Year | N/A | $6.03 |
| Revenue Next Year | N/A | $5.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.12 |
| 52 Week Low | $13.76 | $6.90 |
| 52 Week High | $61.59 | $12.23 |
Technical Indicators
Market Signals| Indicator | JANX | EXPI |
|---|---|---|
| Relative Strength Index (RSI) | 28.18 | 30.64 |
| Support Level | $13.82 | $9.55 |
| Resistance Level | $14.49 | $9.94 |
| Average True Range (ATR) | 0.61 | 0.34 |
| MACD | 0.08 | -0.12 |
| Stochastic Oscillator | 9.76 | 6.89 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.